Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Rituximab

HBV reactivation following intrathecal administration in an elderly patient: case report

    • 8 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Kim M-G, Park SY, Kim EJ, Kim Y-M, Kim HY, Lee YK, Zang DY, Kim HJ.Hepatitis B virus reactivation in a primary central nervous system lymphoma patient following intrathecal rituximab treatment. Acta Haematologica 125: 121-124, No. 3, Mar 2011. Available from: URL: http://dx.doi.org/10.1159/000321792 - South Korea

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Rituximab. React. Wkly. 1351, 37 (2011). https://doi.org/10.2165/00128415-201113510-00128

    Download citation

    Keywords

    • Hepatitis
    • Lymphoma
    • Patient Outcome
    • Liver Function
    • Congenital Anomaly